Tag: biopharmaceutical

biopharmaceutical

Latest News

Lawmakers and visitors participate in an exposition about medical products held in Daegu on July 3.

Biopharmaceutical exports on track to hit record $4.5B in H1

Outbound shipments in the category are set to post a record with a projected on-year increase of 15.3 percent.

2026.7.8

Celltrion Q2 operating profit more than triples on high-margin biosimilars

Celltrion, a major Korean biopharmaceutical firm, estimated that its second-quarter operating profit more than tripled from a year earlier on robust sales of high-margin biosimilar products.

2025.7.21

Most popular

Trade, Industry, and Energy Minister Lee Chang-yang, left, looks around the Seoul Biohub in Dongdaemun District, eastern Seoul, on Wednesday. [MINISTRY OF TRADE, INDUSTRY AND ENERGY]

Korea aims to become biopharm product powerhouse

Korea aims to become a global leading manufacturing powerhouse for biopharmaceutical products and hit $50 billion in bio-related sector exports by 2030.

2023.7.19

John Rim, Samsung Biologics CEO, speaks during a press conference held in Boston on Monday. [YONHAP]

Samsung Biologics’ new production plant to be ready by April 2025

Samsung Biologics’ upcoming $1.5-billion production plant will be ready for operation by April 2025, five months earlier than previously expected, according to the pharmaceutical company Monday.

2023.6.6

Korea's bio industry expands at record speeds during Covid pandemic

The output and exports of Korea's bio industry expanded at the fastest speed ever in 2020 amid the coronavirus pandemic, data showed Monday.

2021.12.20

'Biohealth' exports to break $10 billion for second straight year

"Biohealth" exports totaled $14.3 billion this year through November, a record high, according to data provided by the Ministry of Trade, Industry and Energy, though exports of these products fell on year in November.

2021.12.9

Vials of Covid-19 Pfizer vaccines on Sept. 23 [NEWS1]

Bio booms on big licensing deals with global players

It's been a banner year for Korean biopharmaceutical companies as more have been winning big licensing deals to transfer technologies to global players.

2021.9.26

Biopharm exports double from growing demand during pandemic

Korea's exports of biopharmaceutical products more than doubled in 2020 from a year earlier on the back of the growing demand for pharmaceutical products amid the Covid-19 pandemic, a report showed Monday.

2021.7.26

SK Biopharmaceuticals' epilepsy drug, Cenobamate [SK BIOPHARMACEUTICALS]

SK Biopharm epilepsy drug Cenobamate enters European market

SK Biopharmaceuticals' epilepsy drug Cenobamate has begun sales in Europe, launching initially in Germany under the name Ontozry in early June.

2021.6.16

SK Holdings invests in biopharmaceutical firm

SK Holdings has invested in a Singapore-based biopharmaceutical company, Hummingbird Bioscience, as the lead investor in a Series B funding round worth $25 million, SK said Monday.

2020.5.11